Profile photo Bart de Keizer

Bart de Keizer

Research Staff Other

Strategic program(s):

Biography

Bart de Keizer is a highly skilled radiologist and nuclear medicine physician  affiliated with UMC Utrecht and the Princess Máxima Center for Pediatric Oncology in Utrecht, the Netherlands. He completed his medical degree at UMC Utrecht in 2002, followed by a PhD in Nuclear Medicine in 2004. Dr. de Keizer holds board certifications in both nuclear medicine (2006) and radiology (2015). With over two decades of experience, he plays a pivotal role in imaging departments, combining expertise in both adult and pediatric oncology care. Dr. de Keizer continues to contribute to advancements in medical imaging and treatment. a distinguished researcher in oncology with a specialization in nuclear therapy and diagnostic imaging. His expertise spans a range of cancers, including thyroid cancer, head and neck cancer, and pediatric oncology. 

Research and Publications

Dr. de Keizer's research is dedicated to advancing the diagnostics of oncological diseases. By evaluating current diagnostic scans and introducing new imaging techniques, his work aims to enable image-guided treatments that could increase the cure rates for cancer patients.

In recent years, Dr. de Keizer has been instrumental in the introduction of several new radioactive tracers and PET scans. Notable examples include:

  • Fluor-18-choline PET-CT for detecting parathyroid adenomas
  • Gallium-68-tilmanocept PET-CT for sentinel lymph node detection
  • Fluor-18-MFBG for detecting neuroblastoma
 
 
 

 

 

Associate Professor lecture

Nieuwe scantechnieken voor beeldgestuurde interventies": https://www.youtube.com/watch?v=97FmYAa8LuE

Strategic program(s):

Contact

Research groups

Decision support systems for precision care in translational cancer-imaging

Research aim

To develop, validate and implement decision support systems based on imaging for the diagnosis, prognosis and triaging of oncology patients

Go to group

Advanced imaging for oncology group

Research aim

To enhance patient outcomes through improved cancer staging, enabling personalized treatments with advanced diagnostics.

Go to group

Recent publications

[18F]Tetrafluoroborate PET/CT for detecting differentiated thyroid cancer Hannelore I Coerts, Tessa M van Ginhoven, W Edward Visser, Albert D Windhorst, Menno R Vriens, Marc J C van Treijen, Bart de Keizer, Frederik A Verburg
Future Oncology, 2025, vol. 21, p.3167-3174
The 2025 ATA guidelines for differentiated thyroid Cancer - Ten years of professional debate and measured progress Petra Petranović Ovčariček, Frederik Anton Verburg, Bart de Keizer, Alfredo Campennì, Murat Tuncel, Michael C Kreissl, Désirée Deandreis, Luca Giovanella
European Journal of Nuclear Medicine and Molecular Imaging, 2025, vol. 53, p.2213–2216
Intra-arterial Hepatic 177Lu-PSMA-Radioligand Therapy in Liver-Dominant Metastatic Castration-Resistant Prostate Cancer Ruben K. Fakkert, Arthur J.A.T. Braat, Bart de Keizer, Rutger C.G. Bruijnen, Cheryl P. Bruijnen, Alex J. Poot, Maarten L.J. Smits, Marnix G.E.H. Lam
Cardiovascular and Interventional Radiology, 2025, vol. 49, p.324-329
Long-term effects of premenopausal risk-reducing salpingo-oophorectomy on bone mineral density Maarten J Beekman, Lara Terra, Anniek Stuursma, Bernadette A M Heemskerk-Gerritsen, Jeanine E Roeters van Lennep, Marc van Beurden, Lena C van Doorn, Joanne A de Hullu, Eleonora B L van Dorst, Constantijne H Mom, Brigitte F M Slangen, Christina Mitea, Riemer H J A Slart, Miranda M Snoeren, Marcel P Stokkel, Hein J Verberne, Bart de Keizer, Catharina M Korse, Katja N Gaarenstroom, Klaartje van Engelen, Lizet E van der Kolk, J Margriet Collée, Marijke R Wevers, Margreet G E M Ausems, Lieke P V Berger, Encarna B Gomez Garcia, Christi J van Asperen, Maartje J Hooning, Angela H E M Maas, Marian J E Mourits, Flora E van Leeuwen, M Carola Zillikens
Osteoporosis International, 2025, vol. 36, p.2307-2317
Prognostic value of premaintenance FDG PET/CT response in patients with newly diagnosed myeloma from the CASSIOPEIA trial Françoise Kraeber-Bodere, Bastien Jamet, Sonja Zweegman, Aurore Perrot, Cyrille Hulin, Denis Caillot, Thierry Facon, Xavier Leleu, Karim Belhadj, Emmanuel Itti, Lionel Karlin, Clement Bailly, Mark-David Levin, Monique C Minnema, Caroline Bodet-Milin, Bart de Keizer, Jill Corre, Pieter Sonneveld, Philippe Moreau, Thomas Carlier, Cyrille Touzeau
Blood, 2025, vol. 146, p.3050-3058
[18F]FDG PET/CT to reduce the need for sentinel lymph node biopsy in early-stage oral cancer Roosmarijn S Tellman, Dominique N V Donders, Anne I J Arens, Koos Boeve, Adrienne H Brouwers, Simone E J Eerenstein, Sylvia L van Egmond, Thomas J W Klein Nulent, W Martin C Klop, Martin Lacko, Jochem A J van der Pol, Daphne D D Rietbergen, Robert P Takes, Joris Tim, Wouter V Vogel, Gerben J C Zwezerijnen, Bart de Keizer, Remco de Bree
PLoS ONE, 2025, vol. 20